Pathogenesis, diagnosis and treatment of Rasmussen encephalitis: a European consensus statement.
about
Etiologies of epilepsy: a comprehensive reviewUtility of Plasmapheresis in Autoimmune-Mediated Encephalopathy in Children: Potentials and ChallengesAutoimmune encephalitis in childrenGuidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue.Differential diagnoses of cerebral hemiatrophy in childhood: a review of literature with illustrative report of two cases.Rasmussen's encephalitis: clinical features, pathobiology, and treatment advances.Overlap between linear scleroderma, progressive facial hemiatrophy and immune-inflammatory encephalitis in a paediatric cohort.Rasmussen encephalitis with dual pathology in a patient without seizures: case report and literature review.Expanding Role of T Cells in Human Autoimmune Diseases of the Central Nervous System.Diagnostic and pathogenic significance of glutamate receptor autoantibodies.The history of Kazan neurological school.Evolution of the EEG in children with Rasmussen's syndrome.Long-term follow-up of febrile infection-related epilepsy syndrome.Guidelines on the use of therapeutic apheresis in clinical practice--evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis.Automated 3D MRI volumetry reveals regional atrophy differences in Rasmussen encephalitis.Autoimmune channelopathies: new antibody-mediated disorders of the central nervous systemRasmussen encephalitis and comorbid autoimmune diseases: A window into disease mechanism?Movement disorders in autoimmune diseases.Altered transporter-mediated neocortical GABA release in Rasmussen encephalitis.Are there susceptibility factors for primary progressive aphasia?Autoimmune encephalitis and its relation to infection.CD8(+) T-cell pathogenicity in Rasmussen encephalitis elucidated by large-scale T-cell receptor sequencing.Acute intermittent porphyria, Rasmussen encephalitis, or both?Rasmussen encephalitis: Response to early immunotherapy in a case of immune-mediated encephalitis.Autoimmune channelopathies of the nervous systemReactions of the immune system in epilepsyImmune-mediated epilepsies.Rasmussen's encephalitis: A case reportPediatric anti-Hu-associated encephalitis with clinical features of Rasmussen encephalitis.Left-right olfactory asymmetry results from antagonistic functions of voltage-activated calcium channels and the Raw repeat protein OLRN-1 in C. elegans.Autoimmune channelopathies.Focal chronic inflammatory epileptic encephalopathy in a patient with malformations of cortical development, with a review of the spectrum of chronic inflammatory epileptic encephalopathy.FASTKD2 nonsense mutation in an infantile mitochondrial encephalomyopathy associated with cytochrome c oxidase deficiency.Neuroprotective intervention by interferon-γ blockade prevents CD8+ T cell-mediated dendrite and synapse loss.Increased activation of Iba1+ microglia in pediatric epilepsy patients with Rasmussen's encephalitis compared with cortical dysplasia and tuberous sclerosis complex.Autoantibodies to glutamate receptors can damage the brain in epilepsy, systemic lupus erythematosus and encephalitis.Human herpes virus 6B: a possible role in epilepsy?Upregulation of adenosine kinase in Rasmussen encephalitis.A clinical approach to diagnosis of autoimmune encephalitis.Inflammasome induction in Rasmussen's encephalitis: cortical and associated white matter pathogenesis.
P2860
Q22305926-CE8D5867-41B5-4AE0-B617-128B698BB37BQ26865785-5A74A271-F281-4675-9854-E5628865DF25Q27010170-81A38018-744E-4198-9008-8EEA1A191173Q30276550-8029A6C3-5D40-4D44-8712-601466FA9B6DQ30619911-8643DF0D-D91B-4036-A400-10B2E0441CEDQ30741122-E6A88D0F-96CE-451C-AD14-1F1A6E629DFCQ30926191-D40E9964-CEFC-4849-912C-F379D63A8D73Q30962933-5FE06E1B-EED0-4166-AFBB-0CA6BB08A9ECQ33770508-FDBE4966-752F-4ED8-BC98-E1754BF65FE2Q33969433-ABA6E2C0-A022-4F01-9E7A-CBB80DB50D64Q34003010-19D822F4-6EA5-4832-8CAE-42DBDCF06C81Q34032547-01F3EC34-135C-409E-A0CC-0AEDE17FE3C9Q34108682-B3165F6C-D6FE-4505-9CC1-929577DF1154Q34122035-E3C8C2F3-9116-49D6-A34C-E14E5AAB5EBAQ34151805-A5FD87D4-CFDE-43C7-A19E-876A78984248Q34167246-C8329523-16C9-4DCD-81F4-DCF74ABEE484Q34198746-6E44B6D3-F38B-4328-A9A1-EDEB484D4155Q34272611-6BA73FBA-9585-40AB-862E-321B5C3FFDA1Q34325070-A9C7FAC9-9A77-40DC-A97E-D346DC763F77Q34332931-2127E228-11AC-4017-A633-2E261CECFCEAQ34460643-EAE6B5BD-FD56-422A-B709-153887941866Q34520675-06436C6C-ED7F-401C-939A-A32605FAFEEAQ34645380-D909D44D-CAAE-4AC1-B35F-D79C71711E16Q35105733-1C7D464B-064D-481A-80DD-F3BA875A37A7Q35151881-E88C9E69-33E3-460E-9AAC-72C6190BFA45Q35224998-AFF241F1-BBDC-442C-865D-AAEE1BABFC73Q35234929-4AF38C81-4A4C-4603-A01E-F1BF89BAA378Q35273202-85D2E85A-0983-4B2E-8691-8C939A433C76Q36092678-991C5A72-6947-4030-8034-08C4BD49BAFBQ36405011-DE6C8061-0889-4DCF-8254-D1DC48088412Q36577209-18452AA7-7AA2-4E0F-B1EA-9284F1658388Q36841998-685DC27A-28BC-413E-A2E4-E739997A8370Q36915427-8F08A13A-0828-4D55-9F76-23E60A483482Q37194982-F79136B3-F134-432F-8B6E-76D253A0688BQ37195038-DEBB5700-A890-4C74-B2A5-A7E02C7177D9Q37203376-DA1BC5B3-DC76-4711-948A-59BFB23C91EDQ37216740-A59DB81B-CB9F-4DF3-865A-3794184C60FFQ37272771-DD423524-2599-4494-9F3E-72A55E99BB80Q37343730-7FD445DA-65F5-4760-B969-2B475AC60A75Q37436424-51196802-7966-431B-A74B-2D02D37AC5EF
P2860
Pathogenesis, diagnosis and treatment of Rasmussen encephalitis: a European consensus statement.
description
2005 nî lūn-bûn
@nan
2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Pathogenesis, diagnosis and tr ...... European consensus statement.
@ast
Pathogenesis, diagnosis and tr ...... European consensus statement.
@en
Pathogenesis, diagnosis and tr ...... European consensus statement.
@nl
type
label
Pathogenesis, diagnosis and tr ...... European consensus statement.
@ast
Pathogenesis, diagnosis and tr ...... European consensus statement.
@en
Pathogenesis, diagnosis and tr ...... European consensus statement.
@nl
prefLabel
Pathogenesis, diagnosis and tr ...... European consensus statement.
@ast
Pathogenesis, diagnosis and tr ...... European consensus statement.
@en
Pathogenesis, diagnosis and tr ...... European consensus statement.
@nl
P2093
P356
P1433
P1476
Pathogenesis, diagnosis and tr ...... European consensus statement.
@en
P2093
Lassmann H
Mantegazza R
Spreafico R
P304
P356
10.1093/BRAIN/AWH415
P407
P577
2005-02-02T00:00:00Z